Marian E. Melish

7.2k total citations · 3 hit papers
74 papers, 5.3k citations indexed

About

Marian E. Melish is a scholar working on Surgery, Infectious Diseases and Epidemiology. According to data from OpenAlex, Marian E. Melish has authored 74 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 21 papers in Infectious Diseases and 17 papers in Epidemiology. Recurrent topics in Marian E. Melish's work include Kawasaki Disease and Coronary Complications (40 papers), Coronary Artery Anomalies (12 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Marian E. Melish is often cited by papers focused on Kawasaki Disease and Coronary Complications (40 papers), Coronary Artery Anomalies (12 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). Marian E. Melish collaborates with scholars based in United States, Japan and Spain. Marian E. Melish's co-authors include Lowell A. Glasgow, Jane C. Burns, Mary P. Glodé, Raquel V. Hicks, Stanford T. Shulman, Wilbert H. Mason, David R. Fulton, Alexa Beiser, Jane W. Newburger and Kyung J. Chung and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Marian E. Melish

68 papers receiving 4.9k citations

Hit Papers

The Treatment of Kawasaki Syndrome with Intravenous Gamma... 1970 2026 1988 2007 1986 1991 1970 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marian E. Melish United States 30 3.3k 2.5k 892 892 804 74 5.3k
Mary P. Glodé United States 40 4.1k 1.2× 3.2k 1.3× 1.5k 1.7× 1.0k 1.2× 737 0.9× 95 7.4k
Anne H. Rowley United States 44 6.9k 2.1× 4.8k 1.9× 1.8k 2.0× 1.3k 1.4× 1.3k 1.6× 127 8.9k
Amy D. Klion United States 48 3.4k 1.0× 2.3k 0.9× 290 0.3× 1.3k 1.4× 425 0.5× 195 8.6k
Jethro Herberg United Kingdom 20 1.5k 0.4× 643 0.3× 261 0.3× 971 1.1× 218 0.3× 55 3.6k
Michael J. Chusid United States 28 1.5k 0.4× 928 0.4× 255 0.3× 757 0.8× 480 0.6× 94 4.0k
David Weill United States 31 3.0k 0.9× 1.3k 0.5× 227 0.3× 236 0.3× 108 0.1× 79 4.3k
Kyung‐Yil Lee South Korea 27 873 0.3× 705 0.3× 235 0.3× 304 0.3× 219 0.3× 147 2.4k
Jason W. Chien United States 38 1.0k 0.3× 1.8k 0.7× 89 0.1× 870 1.0× 733 0.9× 109 6.0k
George E. Pierce United States 31 1.2k 0.4× 926 0.4× 287 0.3× 114 0.1× 348 0.4× 116 3.4k
Péter Jaksch Austria 31 1.9k 0.6× 825 0.3× 237 0.3× 249 0.3× 85 0.1× 204 3.6k

Countries citing papers authored by Marian E. Melish

Since Specialization
Citations

This map shows the geographic impact of Marian E. Melish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marian E. Melish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marian E. Melish more than expected).

Fields of papers citing papers by Marian E. Melish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marian E. Melish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marian E. Melish. The network helps show where Marian E. Melish may publish in the future.

Co-authorship network of co-authors of Marian E. Melish

This figure shows the co-authorship network connecting the top 25 collaborators of Marian E. Melish. A scholar is included among the top collaborators of Marian E. Melish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marian E. Melish. Marian E. Melish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Asim A., Sarah Y. Park, Martin Lindner, et al.. (2025). Plasma Microbial Cell-free DNA Sequencing for the Detection of Kingella kingae Pediatric Spinal Infections. The Pediatric Infectious Disease Journal. 44(6). 582–588. 2 indexed citations
3.
Nerurkar, Vivek R., et al.. (2020). Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease. Frontiers in Pediatrics. 8. 295–295. 14 indexed citations
4.
Choi, So Yung, et al.. (2019). The Importance of Echocardiogram during the Second Week of Illness in Children with Kawasaki Disease. The Journal of Pediatrics. 218. 72–77.e1. 4 indexed citations
6.
Nerurkar, Vivek R., et al.. (2016). Clinical and Imaging Findings in an Infant With Zika Embryopathy. Clinical Infectious Diseases. 63(6). 805–811. 56 indexed citations
7.
Burns, Jane C., Brookie M. Best, Asunción Mejías, et al.. (2008). Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease. The Journal of Pediatrics. 153(6). 833–838.e6. 190 indexed citations
8.
Holman, Robert C., Aaron T. Curns, Ermias D. Belay, et al.. (2005). Kawasaki Syndrome in Hawaii. The Pediatric Infectious Disease Journal. 24(5). 429–433. 52 indexed citations
9.
Burns, Jane C., Wilbert H. Mason, Sarmistha B. Hauger, et al.. (2005). Infliximab treatment for refractory Kawasaki syndrome. The Journal of Pediatrics. 146(5). 662–667. 184 indexed citations
10.
Chua, Pong Kian, Vivek R. Nerurkar, Qigui Yu, et al.. (2000). LACK OF ASSOCIATION BETWEEN KAWASAKI SYNDROME AND INFECTION WITH PARVOVIRUS B19, HUMAN HERPESVIRUS 8, TT VIRUS, GB VIRUS C/HEPATITIS G VIRUS OR CHLAMYDIA PNEUMONIAE. The Pediatric Infectious Disease Journal. 19(5). 477–479. 27 indexed citations
11.
Yamamoto, Loren G., et al.. (1998). A revised decision analysis of strategies in the management of febrile children at risk for occult bacteremia. The American Journal of Emergency Medicine. 16(2). 193–207. 10 indexed citations
12.
Abe, Jun, Brian L. Kotzin, Cody Meissner, et al.. (1993). Characterization of T cell repertoire changes in acute Kawasaki disease.. The Journal of Experimental Medicine. 177(3). 791–796. 159 indexed citations
13.
Melish, Marian E.. (1992). Kawasaki Syndrome: A 1992 Update. Pediatric Dermatology. 9(4). 335–337. 2 indexed citations
14.
Baker, Carol J., Marian E. Melish, Robert T. Hall, et al.. (1992). Intravenous Immune Globulin for the Prevention of Nosocomial Infection in Low-Birth-Weight Neonates. New England Journal of Medicine. 327(4). 213–219. 106 indexed citations
15.
Newburger, Jane W., Masato Takahashi, Alexa Beiser, et al.. (1991). A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome. New England Journal of Medicine. 324(23). 1633–1639. 884 indexed citations breakdown →
16.
Burns, Jane C., Wilbert H. Mason, Mary P. Glodé, et al.. (1991). Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. The Journal of Pediatrics. 118(5). 680–686. 133 indexed citations
17.
Melish, Marian E., et al.. (1989). Endotoxin Is Not an Essential Mediator in Toxic Shock Syndrome. Clinical Infectious Diseases. 11(Supplement_1). S219–S230. 11 indexed citations
18.
Olson, Richard D., Dennis L. Stevens, & Marian E. Melish. (1989). Direct Effects of Purified Staphylococcal Toxic Shock Syndrome Toxin 1 on Myocardial Function of Isolated Rabbit Atria. Clinical Infectious Diseases. 11(Supplement_1). S313–S315. 18 indexed citations
19.
James, J. F., et al.. (1989). Effect of Magnesium on in Vitro Production of Toxic Shock Syndrome Toxin 1. Clinical Infectious Diseases. 11(Supplement_1). S157–S166. 3 indexed citations
20.
Melish, Marian E.. (1983). Kawasaki Syndrome in the United States (川崎病の成因をめぐって ). 24(3). 281–292. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026